2026 NPPES data Urology Physician NPI 1144621657 M.D.
Verify on CMS →

MARK FERRETTI, M.D.

Urology Physician in LAKEWOOD, New Jersey. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
1K
Medicare Part D claims · 386 beneficiaries · Urology Physician avg: 1K
Generic prescribing
95%
generic claims · 5% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$821.31
20 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: MARK FERRETTI, M.D. is a Urology Physician ([object Object]) practicing in LAKEWOOD, New Jersey with a Medicare Part D prescribing footprint of 1K claims across 386 beneficiaries — 5% brand-name prescribing . Industry payments of $821.31 across 20 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: MARK FERRETTI, M.D. filed 1,112 Medicare Part D claims in 2023 across LAKEWOOD, New Jersey. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

MARK FERRETTI, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 3 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

MARK FERRETTI, M.D. at a glance

Quality data not reported

NPI registry status

Active

Issued 09/16/2014

NPI 1144621657

Primary specialty

Urology Physician

Mid-sized

13,350 US NPIs in this specialty

Medicare Part D claims

1,112 13% vs specialty avg

2023 prescription claims

Specialty avg: 1,280

Specialty distribution in New Jersey

How Urology Physician compares to other specialties among New Jersey providers

New Jersey providers

Urology Physician share within New Jersey

1. Urology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Urology Physician share within New Jersey

Specialty board-certification context

Estimated specialty board-certified rate — Urology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Urology Physician ABMS/AOA estimate

Est. board-certified rate (Urology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Urology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARK FERRETTI, M.D. is a Urology Physician provider practicing in LAKEWOOD, New Jersey, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1144621657. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MARK FERRETTI, M.D. appears in the CMS NPPES registry as a Urology Physician provider holding M.D. credentials at 456 CHESTNUT ST UNIT 302, LAKEWOOD, NJ, 08701, with a listed phone of (732) 523-5110. NPI 1144621657 was issued on 09/16/2014. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what FERRETTI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,112 prescription claims written by this provider, covering 386 Medicare beneficiaries and totaling roughly $31K in drug spend, split 5% brand-name and 95% generic by claim count, with an opioid prescribing rate of 3.0%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Urology Physician is a mid-sized specialty nationwide, with 13,350 enrolled providers across 54 states and an average of 1,280 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

456 CHESTNUT ST UNIT 302
LAKEWOOD, NJ 08701

Provider Details

NPI 1144621657
Specialty Urology Physician
Credentials M.D.
Gender Male
NPI Issued 09/16/2014

Hospital and facility affiliations

Facilities where MARK FERRETTI, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

BARNABAS HEALTH MEDICAL GROUP PC
TOMS RIVER, NJ
GEISINGER CLINIC
WILKES BARRE, PA
UNITED HEALTH SERVICES HOSPITALS, INC.
BINGHAMTON, NY

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARK FERRETTI, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$821

Largest payer

PROCEPT BioRobotics Corporation

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Generic-heavy

MARK FERRETTI, M.D. — brand share 5.0%
Specialty average (est.)

5% brand-name claims vs 95% generic, on 1,112 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,112
Total Claims
$31K
Total Drug Cost
386
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,815
Total Day Supply
47,884
Brand vs Generic
5% brand / 95% generic
Brand Drug Cost
$12K
Generic Drug Cost
$18K
Opioid Claims
33 (3.0% rate)
Antibiotic Claims
227

Patient Demographics

Average Patient Age
74.1 years
Avg HCC Risk Score
1.49
Gender Split
17% female / 83% male
Age Distribution
<65: 38, 65-74: 164, 75-84: 133, 85+: 51

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Tamsulosin Hcl
346
Finasteride
267
Sulfamethoxazole-Trimethoprim
Sulfamethoxazole/Trimethoprim
75
Alfuzosin Hcl Er
Alfuzosin Hcl
55
Oxybutynin Chloride Er
Oxybutynin Chloride
55
Ciprofloxacin Hcl
42
Nitrofurantoin Mono-Macro
Nitrofurantoin Monohyd/M-Cryst
41
Cefdinir
25
Oxycodone-Acetaminophen
Oxycodone Hcl/Acetaminophen
23
Myrbetriq
Mirabegron
22

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Urology Physician Overview

How MARK FERRETTI, M.D. fits within the Urology Physician landscape nationally.

13,350
Urology Physician Providers in US
54
States with Urology Physician
1,280
Avg Claims per Provider

MARK FERRETTI, M.D.'s 1,112 claims are below the specialty average of 1,280.

Nearby Urology Physician Providers in New Jersey

Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as FERRETTI.

Compare Urology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARK FERRETTI, M.D.'s specialty?
MARK FERRETTI, M.D. specializes in Urology Physician and practices in LAKEWOOD, New Jersey. Credentials: M.D..
How much does MARK FERRETTI, M.D. prescribe under Medicare Part D?
In 2023, MARK FERRETTI, M.D. wrote 1,112 Medicare Part D claims totaling $31K in drug costs for 386 beneficiaries.
Where is MARK FERRETTI, M.D. located?
MARK FERRETTI, M.D. is located at 456 CHESTNUT ST UNIT 302, LAKEWOOD, NJ, 08701. Phone: (732) 523-5110.
What is MARK FERRETTI, M.D.'s NPI number?
MARK FERRETTI, M.D.'s National Provider Identifier (NPI) is 1144621657, issued on 09/16/2014.
Does MARK FERRETTI, M.D. prescribe more brand-name or generic drugs?
MARK FERRETTI, M.D.'s prescribing is 5% brand-name and 95% generic drugs by claim count, with $12K in brand drug costs.
Does MARK FERRETTI, M.D. prescribe opioids?
Yes, MARK FERRETTI, M.D. had 33 opioid claims in 2023 with an opioid prescribing rate of 3.0%.
How many Urology Physician providers are there in the US?
There are 13,350 Urology Physician providers across 54 states in the US. The average Urology Physician provider writes 1,280 Medicare Part D claims per year.
What drugs does MARK FERRETTI, M.D. prescribe most often?
Based on 2023 Medicare Part D data, MARK FERRETTI, M.D.'s most frequently prescribed drugs include Tamsulosin Hcl, Finasteride, Sulfamethoxazole-Trimethoprim. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARK FERRETTI, M.D. accept Medicare?
MARK FERRETTI, M.D. appears in CMS Medicare data with 1,112 Part D claims and 386 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARK FERRETTI, M.D.'s credentials?
MARK FERRETTI, M.D.'s NPI is 1144621657 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology